Back

Predictive Oncology Prices $344.4 Million PIPE Deals for ATH Token Strategy

The Nasdaq-listed firm plans cash and crypto PIPE transactions to support a digital asset treasury focused on Aethir’s ATH token, with closing expected in early October 2025.

ATH

Summary

Predictive Oncology Inc. announced the pricing of two PIPE transactions totaling approximately $344.4 million to execute its digital asset treasury strategy based on Aethir’s ATH token. The cash PIPE will generate about $51.7 million through 66.7 million shares sold at $0.7751 each. The crypto PIPE will see up to 223.6 million pre-funded warrants issued in exchange for locked and unlocked ATH tokens valued at a discounted $173.3 million. Both deals are anticipated to close around October 2, 2025, pending customary conditions.

Terms & Concepts
  • PIPE (Private Investment in Public Equity): A financing arrangement where private investors purchase publicly traded shares directly from the issuing company, often at a discount.
  • Digital Asset Treasury Strategy: A corporate financial approach involving the use of cryptocurrencies or tokens as part of a company's reserve or investment portfolio.
  • ATH Token: A digital token associated with Aethir’s blockchain platform, used within its ecosystem for transactions and staking.